Ultragenyx Pharmaceutical Inc. buy melinda
Start price
31.08.17
/
50%
€50.68
Target price
26.12.17
€63.14
Performance (%)
-14.69%
End price
26.12.17
€43.23
Summary
This prediction ended on 26.12.17 with a price of €43.23. The price of Ultragenyx Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.69%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | -5.314% | -5.314% | 0.513% | -44.000% |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by melinda for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
zu folgen
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€73.50
25.08.20
25.08.20
€77.00
04.11.21
04.11.21
1.36%
05.11.21
05.11.21
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€57.91
23.06.17
23.06.17
€76.67
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.20
23.06.17
23.06.17
€85.00
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.19
05.01.17
05.01.17
€76.67
27.02.17
27.02.17
12.65%
27.02.17
27.02.17